文献速递胃肠外科急腹症与外科感染

生物性与生物合成可吸收补片加强腹腔镜食管裂孔疝修补术的13年经验

A 13-year experience with biologic and biosynthetic absorbable mesh reinforced laparoscopic paraesophageal hernia repair.
PubMed 文献 · Surg Endosc · 2023-07-05

单中心回顾性分析2008年10月至2021年9月473例采用可吸收补片加强腹腔镜食管裂孔疝修补术的患者,比较生物补片、 heavyweight合成生物可吸收补片与lightweight合成生物可吸收补片的预后。总体复发率16.7%,三组间2年内复发率无显著差异,但lightweight组复发中位时间较短(10个月,p=0.016)。

要点

  • 473例可吸收补片加强腹腔镜食管裂孔疝修补术中,总体复发率为16.7%。
  • 生物补片、heavyweight与lightweight合成生物可吸收补片三组间2年内复发率无显著差异。
  • lightweight组复发中位时间较短(10个月,p=0.016)。

核心结论

  • 采用可吸收补片加强腹腔镜食管裂孔疝修补术可行且安全,术后2年内无论选择何种补片,患者报告结局(包括吞咽困难)相当。
  • 生物补片、heavyweight或lightweight合成生物可吸收补片在术后2年内复发率无显著差异。

研究设计与样本

  • 单中心回顾性综述,纳入2008年10月至2021年9月期间所有接受可吸收补片加强腹腔镜食管裂孔疝修补术的患者473例。
  • 补片类型包括:生物补片(n=83)、heavyweight合成生物可吸收补片(n=261)、lightweight合成生物可吸收补片(n=111)。
  • 复发定义为影像学或内镜下垂直胸腔内胃>2 cm;若无可用检查则视为无复发。

主要发现

  • 疝类型分布:2型1.3%、3型86.0%、4型12.7%。
  • 三组间年龄、ASA评分、BMI、性别、吸烟状态、慢性激素使用、术前抑酸治疗、疝类型或复发疝均无显著差异;术后30天结局无显著差异。
  • 术后1年和2年时点反流症状指数、GERD-HRQL和吞咽困难评分无显著差异。
  • 总体复发率为16.7%,生物补片、heavyweight与lightweight合成生物可吸收补片三组间术后2年内复发率无显著差异。
  • lightweight组复发中位时间较短(10个月,p=0.016)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mesh reinforced cruroplasty during laparoscopic paraesophageal hernia repair remains controversial due to wide variation in surgical technique and mesh composition. This study aims to review outcomes and rates of recurrence following laparoscopic paraesophageal hernia repair (LPEHR) with mesh reinforced cruroplasty utilizing absorbable mesh at a single institution. METHODS: A retrospective review of all patients who underwent LPEHR with mesh was performed. Medical records were reviewed for patient reported, radiographic or endoscopic evidence of recurrence, defined as > 2 cm of vertical intrathoracic stomach. If no studies were available for review, patients were considered to have no recurrence. Outcomes and mesh-related complications were also reviewed. RESULTS: Between 10/2008 and 9/2021, 473 patients underwent LPEHR with absorbable mesh; 1.3% type 2 hernias, 86.0% type 3 hernias, 12.7% type 4 hernias. Three types of mesh were used: initially biologic mesh (n = 83), then heavyweight synthetic bioabsorbable mesh (n = 261), and finally lightweight synthetic bioabsorbable mesh (n = 111). There were no significant differences in age, ASA, BMI, gender, smoking status, chronic steroid use, preoperative acid suppression, hernia type, or recurrent hernia between groups. There were no significant differences in 30-day postoperative outcomes. Reflux Symptom Index, GERD-HRQL, and Dysphagia Scores at 1- and 2-year postoperative timepoints were not significantly different. The overall recurrence rate was 16.7%, with no significant differences in recurrence rates between biologic, heavyweight or lightweight biosynthetic absorbable mesh through 2 years after surgery. A shorter median time to recurrence (10 months, p = 0.016) was seen in the lightweight group. CONCLUSION: LPEHR with absorbable mesh reinforced cruroplasty is feasible and safe, with equivalent patient-reported outcomes, including dysphagia, up to 2-years postop regardless of mesh choice. No significant differences in recurrence rates between biologic, heavyweight, or lightweight synthetic bioabsorbable mesh were seen up to 2 years after LPEHR.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Amundson JR, Kuchta K, Wu H, et al. A 13-year experience with biologic and biosynthetic absorbable mesh reinforced laparoscopic paraesophageal hernia repair. Surg Endosc. 2023. PMID: 37407714. doi:10.1007/s00464-023-10248-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。